Skip to content

Association Between Venous Excess Ultrasound Grading System and Acute Kidney Injury in the ICU Population

The Association Between Venous Excess Ultrasound, the Lung Ultrasound Score and Acute Kidney Injury and Death in the Intensive Care Unit Population

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06585722
Acronym
VExUS ICU
Enrollment
136
Registered
2024-09-05
Start date
2023-02-01
Completion date
2024-09-05
Last updated
2024-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fluid Overload, Kidney Injury, Make-30

Brief summary

Fluid resuscitation is one of the cornerstones of treatment in ICU patients. Nonetheless, excessive fluid administration can lead to fluid overload which has been associated with worse outcomes in the ICU. To prevent this, assessments of fluid responsiveness are commonly employed. However, fluid responsiveness does not take fluid tolerance into account. Fluid tolerance is the idea that a patient might still be fluid responsive but might already be at risk of the detrimental effects of fluid therapy. Recent developments in point of care ultrasound e.g. the Venous excess ultrasound might help identify patients at risk of fluid overload. However its association with patient relevant outcomes in the ICU remains unclear.

Detailed description

This study will investigate the association between the venous excess ultrasound grading system (VExUS) and patient relevant outcomes such as acute kidney injury, mortality and length of stay. A secondary analysis is planned where the association between VExUS and the lung ultrasound score will be investigated

Interventions

None listed

Sponsors

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* all patients admitted to the ICU 18 years or older expected to stay in the ICU for more than 24 hours

Exclusion criteria

* any obstruction between the righ atrium and structures assessed by VExUS * a medical history of: Major cardiac shunts (e.g. atrial septum defect), Tricuspid regurgitation, dialysis, portal hypertension, pulmonary hypertension, interstitial lung disease, recipients of a kidney of liver transplant. * patients in whom an ultrasound assesment is unfeasible e.g. a BMI over 40

Design outcomes

Primary

MeasureTime frameDescription
Rate of acute kidney injurywithin 30 days of admission to the ICUClinically relevant acute kidney injury in the ICU: a 200% rise in creatinine or the use of renal replacement therapy
Mortalitywithin 30 days of admission to the ICUdeath of all causes
Rate of MAKE-30within 30 days of admission to the ICUa composite endpoint of mortality and acute kidney injury ( including renal replacement therapy)

Other

MeasureTime frameDescription
Lung ultrasound scoremaximum of 3 times during the first 7 days of admissiona score for lung aeration as assessed by ultrasound ranging from 0 to 36 where 0 is the normal physiological state
Cardiac function as assed by ultrasoundmaximum of 3 times during the first 7 days of admissiondetermined by eyeballing and measurement of the tricuspid annular plane systolic excursion (\>16 is normal)

Countries

Netherlands

Contacts

Primary ContactPieter R Tuinman, PhD
p.tuinman@amsterdamumc.nl0204444444
Backup ContactP Klompmaker, MSc
p.klompmaker@amsterdamumc.nl0204444444

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026